Lu; Xian-Ping

Patent Applications and Registrations

Patent applications and USPTO patent grants for Lu; Xian-Ping.The latest application filed is for "naphthamide derivatives as multi-target protein kinase inhibitors and histone deacetylase inhibitors".

Company Profile

0.11.12

Lu; Xian-Ping - Belle Meade NJ
Lu; Xian-Ping - Shenzhen CN
Lu; Xian-Ping - Quangdong CN
Lu; Xian-Ping - Guangdong CN
Lu; Xian-Ping - San Diego CA
Lu, Xian-Ping - Belle Mead NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Naphthamide derivatives as multi-target protein kinase inhibitors and histone deacetylase inhibitors Grant 8,211,901 - Lu , et al. July 3, 2	2012-07-03
Tricyclic derivatives as potent and selective histone deacetylase inhibitors Grant 8,178,577 - Lu , et al. May 15, 2	2012-05-15
2-indolinone derivatives as multi-target protein kinase inhibitors and histone deacetylase inhibitors Grant 8,158,656 - Lu , et al. April 17, 2	2012-04-17
2-indolinone derivatives as selective histone deacetylase inhibitors Grant 7,863,315 - Lu , et al. January 4, 2	2011-01-04
Naphthamide Derivatives As Multi-Target Protein Kinase Inhibitors and Histone Deacetylase Inhibitors App 20100298358 - LU; Xian-Ping ; et al.	2010-11-25
2-indolinone Derivatives As Multi-target Protein Kinase Inhibitors And Histone Deacetylase Inhibitors App 20090298886 - LU; Xian-Ping ; et al.	2009-12-03
Tricyclic Derivatives As Potent And Selective Histone Deacetylase Inhibitors App 20090292001 - LU; Xian-Ping ; et al.	2009-11-26
2-indolinone Derivatives As Selective Histone Deacetylase Inhibitors App 20090182029 - Lu; Xian-Ping ; et al.	2009-07-16
Benzamide derivatives as histone deacetylase inhibitors with potent differentiation and anti-proliferation activity Grant 7,550,490 - Lu , et al. June 23, 2	2009-06-23
Substituted arylalcanoic acid derivatives as ppar pan agonists with potent antihyperglycemic and antihyperlipidemic activity App 20080051321 - Lu; Xian-Ping ; et al.	2008-02-28
Histone Deacetylase Inhibitors or Novel Benzamine Derivatives with Potent Differentiation and Anti-Proliferation Activity App 20080039509 - Lu; Xian-Ping ; et al.	2008-02-14
Substituted arylalcanoic acid derivatives as PPAR pan agonists with potent antihyperglycemic and antihyperlipidemic activity Grant 7,268,157 - Lu , et al. September 11, 2	2007-09-11
Histone deacetylase inhibitors of novel benzamide derivatives with potent differentiation and anti-proliferation activity Grant 7,244,751 - Lu , et al. July 17, 2	2007-07-17
Noncyclic 1,3-Dicarbonyl compounds as dual PPAR agonists with potent antihyperglycemic and antihyperlipidemic activity App 20070142427 - Lu; Xian-Ping ; et al.	2007-06-21
Noncyclic 1,3-dicarbonyl compounds as dual PPAR agonists with potent antihyperglycemic and antihyperlipidemic activity Grant 7,192,970 - Lu , et al. March 20, 2	2007-03-20
Compositions of flavones and long chain fatty acid derivatives isolated from plants and methods related thereto for the control of prostate disorders App 20060252708 - Lu; Xian-Ping ; et al.	2006-11-09
Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents, especially for cervical cancers and dysplasias Grant 6,825,226 - Pfahl , et al. November 30, 2	2004-11-30
Histone deacetylase inhibitors of novel benzamide derivatives with potent differentiation and anti-proliferation activity App 20040224991 - Lu, Xian-Ping ; et al.	2004-11-11
Substituted arylalcanoic acid derivatives as PPAR pan agonists with potent antihyperglycemic and antihyperlipidemic activity App 20040142921 - Lu, Xian-Ping ; et al.	2004-07-22
Noncyclic 1,3-dicarbonyl compounds as dual PPAR agonists with potent antihyperglycemic and antihyperlipidemic activity App 20040138211 - Lu, Xian-Ping ; et al.	2004-07-15
Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents, especially for cervical cancers and dysplasias App 20030073745 - Pfahl, Magnus ; et al.	2003-04-17
Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents, especially for cervical cancers and dysplasias Grant 6,462,064 - Pfahl , et al. October 8, 2	2002-10-08
Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents Grant 6,127,415 - Pfahl , et al. October 3, 2	2000-10-03

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.